I presume you’re referring to MNTA; however, there are several other biotechs among the 19 stocks listed in the My Stocks section of my iHub portfolio:
• ABT makes the world’s biggest-selling biopharmaceutical (Humira). How is it not a biotech?
• PFE sells Enbrel and Prevnar/Prevnar 13, two of the world’s premiere biologics franchises. How is it not a biotech?
• NVS may have more commercially successful first-in-class drugs than any other company. How is it not a biotech?
• AGN makes Botox, which is not only a blockbuster, but also the world’s most versatile biologic. How is it not a biotech?
• MON is the world’s leading supplier of genetically-modified seeds. How is it not a biotech?
• PKI is the world’s leading vendor of neonatal tests for genetic diseases and is also in the business of banking cord blood. How is it not a biotech?
In short, your definition of biotech is evidently narrower than mine. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.